SOPHiA GENETICS S.A.
SOPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $65,173 | $62,371 | $47,560 | $40,450 |
| % Growth | 4.5% | 31.1% | 17.6% | – |
| Cost of Goods Sold | $21,236 | $19,458 | $16,306 | $15,229 |
| Gross Profit | $43,937 | $42,913 | $31,254 | $25,221 |
| % Margin | 67.4% | 68.8% | 65.7% | 62.4% |
| R&D Expenses | $34,366 | $36,969 | $35,371 | $26,578 |
| G&A Expenses | $46,953 | $53,301 | $55,816 | $41,505 |
| SG&A Expenses | $76,322 | $81,724 | $84,083 | $70,240 |
| Sales & Mktg Exp. | $29,369 | $28,423 | $28,267 | $28,735 |
| Other Operating Expenses | -$183 | -$954 | -$377 | -$108 |
| Operating Expenses | $110,505 | $117,739 | $119,077 | $96,710 |
| Operating Income | -$66,568 | -$74,826 | -$87,823 | -$71,489 |
| % Margin | -102.1% | -120% | -184.7% | -176.7% |
| Other Income/Exp. Net | $5,298 | -$3,669 | $238 | -$2,018 |
| Pre-Tax Income | -$61,270 | -$78,495 | -$87,585 | -$73,507 |
| Tax Expense | $1,223 | $486 | -$136 | $168 |
| Net Income | -$62,493 | -$78,981 | -$87,449 | -$73,675 |
| % Margin | -95.9% | -126.6% | -183.9% | -182.1% |
| EPS | -0.95 | -1.22 | -1.36 | -1.33 |
| % Growth | 22.1% | 10.3% | -2.3% | – |
| EPS Diluted | -0.95 | -1.22 | -1.36 | -1.33 |
| Weighted Avg Shares Out | 65,782 | 64,751 | 64,099 | 55,300 |
| Weighted Avg Shares Out Dil | 65,782 | 64,751 | 64,099 | 55,300 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,362 | $4,547 | $1,324 | $20 |
| Interest Expense | $1,913 | $588 | $639 | $658 |
| Depreciation & Amortization | $8,596 | $8,336 | $5,571 | $3,609 |
| EBITDA | -$50,761 | -$69,571 | -$81,375 | -$69,240 |
| % Margin | -77.9% | -111.5% | -171.1% | -171.2% |